Shenzhen Neptunus Interlong Bio-Technique Co (HKSE:08329) Market Cap : HK$469.8 Mil (As of Apr. 15, 2025)

View and export this data going back to 2005. Start your Free Trial

What is Shenzhen Neptunus Interlong Bio-Technique Co Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Shenzhen Neptunus Interlong Bio-Technique Co's share price for the quarter that ended in Jun. 2024 was HK$0.143. Shenzhen Neptunus Interlong Bio-Technique Co's Shares Outstanding (EOP) for the quarter that ended in Jun. 2024 was 1,678.0 Mil. Therefore, Shenzhen Neptunus Interlong Bio-Technique Co's market cap for the quarter that ended in Jun. 2024 was HK$240.0 Mil.

Shenzhen Neptunus Interlong Bio-Technique Co's quarterly market cap stayed the same from Sep. 2023 (HK$275.2 Mil) to Dec. 2023 (HK$275.2 Mil) but then declined from Dec. 2023 (HK$275.2 Mil) to Jun. 2024 (HK$240.0 Mil).

Shenzhen Neptunus Interlong Bio-Technique Co's annual market cap declined from Dec. 2021 (HK$310.4 Mil) to Dec. 2022 (HK$288.6 Mil) and declined from Dec. 2022 (HK$288.6 Mil) to Dec. 2023 (HK$275.2 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Shenzhen Neptunus Interlong Bio-Technique Co's Enterprise Value for Today is HK$388.1 Mil.

Shenzhen Neptunus Interlong Bio-Technique Co Market Cap Historical Data

The historical data trend for Shenzhen Neptunus Interlong Bio-Technique Co's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shenzhen Neptunus Interlong Bio-Technique Co Market Cap Chart

Shenzhen Neptunus Interlong Bio-Technique Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Market Cap

Get a 7-Day Free Trial

578.91

310.43

288.62

275.19

273.51

Shenzhen Neptunus Interlong Bio-Technique Co Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Jun24	Dec24
Market Cap	Get a 7-Day Free Trial															268.48	275.19	275.19	239.95	273.51

Competitive Comparison of Shenzhen Neptunus Interlong Bio-Technique Co's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, Shenzhen Neptunus Interlong Bio-Technique Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shenzhen Neptunus Interlong Bio-Technique Co's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shenzhen Neptunus Interlong Bio-Technique Co's Market Cap distribution charts can be found below:

* The bar in red indicates where Shenzhen Neptunus Interlong Bio-Technique Co's Market Cap falls into.

Save Embed

;

Save Embed

;

Shenzhen Neptunus Interlong Bio-Technique Co Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Shenzhen Neptunus Interlong Bio-Technique Co's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )	=	Share Price (A: Dec. 2023 )	*	Shares Outstanding (EOP) (A: Dec. 2023 )
	=	HK$0.164	*	1678.000
	=	HK$275.2

Shenzhen Neptunus Interlong Bio-Technique Co's Market Cap for the quarter that ended in Jun. 2024 is calculated as

Market Cap (Q: Jun. 2024 )	=	Share Price (Q: Jun. 2024 )	*	Shares Outstanding (EOP) (Q: Jun. 2024 )
	=	HK$0.143	*	1678.000
	=	HK$240.0

Shenzhen Neptunus Interlong Bio-Technique Co (HKSE:08329) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

Shenzhen Neptunus Interlong Bio-Technique Co Market Cap Related Terms

Thank you for viewing the detailed overview of Shenzhen Neptunus Interlong Bio-Technique Co's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

Shenzhen Neptunus Interlong Bio-Technique Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shenzhen Neptunus Interlong Bio-Technique Co Ltd (HKSE:08329) » Definitions » Market Cap

Traded in Other Exchanges

N/A

Address

95 Queensway, 18th Floor, United Centre, Admiralty, Hong Kong, HKG

Website

https://www.interlong.com

Shenzhen Neptunus Interlong Bio-Technique Co Ltd is engaged in the research and development, manufacturing, and selling of medicines and medical devices. It is also involved in the purchase and sales of medicines and healthcare food products. The group's revenue and results from operations are mainly derived from activities in the PRC. The operating segments of the company are the Manufacturing and selling of medicines; and the Sales and distribution of medicines and healthcare products. The majority of revenue is generated from the Manufacturing and selling of medicines.

Shenzhen Neptunus Interlong Bio-Technique Co Headlines

No Headlines